NanoViricides
Stock Forecast, Prediction & Price Target
NanoViricides Financial Estimates
NanoViricides Revenue Estimates
NanoViricides EBITDA Estimates
NanoViricides Earnings per Share Estimates
Passed | Analyst forecast | ||||||
---|---|---|---|---|---|---|---|
Metric | 6/30/2022 | 6/30/2023 | 6/30/2024 | 6/30/2026 | 6/30/2027 | ||
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $3M Low: $3M High: $3M avg. 0% | Avg: $7M Low: $7M High: $7M avg. 133.33% | ||
Net Income
% change YoY
| $-8.10M N/A | $-8.58M -6.03% | $-8.29M 3.42% | Avg: $-12.90M Low: $-12.90M High: $-12.90M avg. -55.59% | Avg: $-4.41M Low: $-4.41M High: $-4.41M avg. 65.76% | ||
EBITDA
% change YoY
| $-7.37M N/A | $-7.84M -6.25% | $-7.75M 1.05% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | ||
EPS
% change YoY
| -$0.7 N/A | -$0.74 -5.71% | -$0.7 5.40% | Avg: -$1.11 Low: -$1.11 High: -$1.11 avg. -58.57% | Avg: -$0.38 Low: -$0.38 High: -$0.38 avg. 65.76% | ||
Operating Expenses
% change YoY
| $8.11M N/A | $8.94M 10.22% | $8.51M -4.77% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is NanoViricides stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 5.08% in 2026-2027.
We have gathered data from N/A analysts. Their low estimate is -12.90M, average is -12.90M and high is -12.90M.
What is NanoViricides stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 66.66% in 2026-2027.
We have gathered data from N/A analysts. Their low revenue estimate is $3M, average is $3M and high is $3M.
What is NanoViricides stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 3.59% in 2026-2027.
We have gathered data from N/A analysts. Their low earnings per share estimate is -$1.11, average is -$1.11 and high is $-1.11.